Future research in SCD should be directed toward evaluating low Hpx as a potential indicator for silent cerebral infarct (by initiating early and regular transcranial imaging), as well as a potential point of pharmaceutical modulation. Here, HPX is linked to Schnyder corneal dystrophy.